|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Portal vein thrombosis:Insight into physiopathology,diagnosis,and treatment显示文摘Portal vein thrombosis (PVT) is a relatively common complication in patients with liver cirrhosis, but might also occur in absence of an overt liver disease. Several causes, either local or systemic, might play an important role in PVT pathogenesis. Frequently, more than one risk factor could be identified; however, occasionally no single factor is discernable. Clinical examination, laboratory investigations, and imaging are helpful to provide a quick diagnosis, as prompt treatment might greatly affect a patient's outcome. In this review, we analyze the physiopathological mechanisms of PVT development, together with the hemodynamic and functional alterations related to this condition. Moreover, we describe the principal factors most frequently involved in PVT development and the recent knowledge concerning diagnostic and therapeutic procedures. Finally, we analyze the implications of PVT in the setting of liver transplantation and its possible influence on patients' future prognoses. | Francesca R Ponziani Maria A Zocco Chiara Campanale Emanuele Rinninella Annalisa Tortora Luca Di Maurizio Giuseppe Bombardieri Raimondo De Cristofaro Anna M De Gaetano Raffaele Landolfi Antonio Gasbarrini | 2010 | World Journal of Gastroenterology2010，16，2： | 75 |
| 2 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)显示文摘 | Bianco C Tortora G Bianco R | 2002 | Clin Cancer Rcs2002，8，10： | 1 |
| 3 | Antitumor activity of eombined treatment of human cancer cells with ionizing radiation and anti - epidermal growth factor receptor monoclona] antibody (2225 plus type 1 protein kinase A antisense olignnucleotide显示文摘 | Bianco C Bianeo R Tortora G | 2000 | Clin Cancer Res2000，6，11： | 1 |
| 4 | Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy显示文摘 | Bianco R Troiani T Tortora G | 2005 | Endocr Relat Cancer2005，12，1： | 1 |
| 5 | 显示文摘 | Maglio G Palumbo R Tortora M | 1998 | Polymer1998，39，25： | 1 |
| 6 | 显示文摘 | Maglio G Palumbo R Tortora M | 2000 | J Polym Sci Part A: Polym Chem2000，38，： | 1 |
| 7 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)显示文摘 | Bianco C Tortora G Bianco R | 2002 | Clin Cancer Res2002，8，10： | 1 |
| 8 | Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth 显示文摘 | Tortora G Caputo R Pomatico G | 1999 | Clin Cancer Res1999，5，： | 1 |
| 9 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) 显示文摘 | Bianco C Tortora G Bianco R | 2002 | Clin Cancer Res2002，8，10： | 1 |
| 10 | Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies 显示文摘 | TORTORA G BIANCO R DANIELE G | 2007 | Drug Resist Updat2007，10，3： | 1 |
| 11 | Enhancement of antitumor activity of ionizing radiation by combined treat- ment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)显示文摘 | Bianco C Tortora G Bianco R | 2002 | Clin Cancer Res2002，8，10： | 1 |
| 12 | Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) 显示文摘 | Bianco C Tortora G Bianco R | 2002 | Olin Cancer Res2002，8，10： | 1 |
| 13 | Cardiovascular risk markers in patients with primary aldosteronism: a systematicreview and meta-analysis of literature studies 显示文摘 | Ambrosino P Lupoli R Tortora A | 2016 | Int J Cardiol2016，208，： | 1 |
| 14 | Combined targeted inhibition of bc1-2, bc1-XL, epidermal growth factor receptor and protein kinase A type Ⅰ cause protent antitumor,apoptotic and antiangiogenie aetivity显示文摘 | Tortora GA Caputo R Damisao V | 2003 | Clin Cancer Res2003，9，： | 1 |
| 15 | Wireless powering for a self- propelled and steerable endoscopic capsule for stomach inspection Biosens 显示文摘 | CARTA R TORTORA G | 2009 | Bioelectron2009，，25： | 1 |
| 16 | Combined targeted inhi- bition of bcl - 2, bcl - xl, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity 显示文摘 | Tortora G Caputo R Damiano V | 2003 | Clin Cancer Res2003，9，2： | 1 |
| 17 | Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor receptor antibody on human breast cancer cell growth显示文摘 | Tortora G Caputo R Pomatico G | 1999 | Clin Cancer Res1999，5，4： | 1 |
| 18 | Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa)显示文摘 | Bianco G Tortora G Bianco R | 2002 | Clin Cancer Res2002，8，10： | 1 |
| 19 | Overcomingresistance to molecularly targeted anticancer therapies: rationaldrug combinations based on EGFR and MAPK inhibition forsolid tumours and haematologic malignancies 显示文摘 | TORTORA G BIANCO R DANIELE G | 2007 | Drug ResistUpdat2007，10，3： | 1 |
| 20 | 查看详情显示文摘 | Gorrasi G Tortora M Vittoria V Kaempfer D Mülhaupt R | | 0，，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员